Truth behind FDA ban on Ranbaxy found: Human hair embedded in tablet
During a visit to a facility of leading drugmaker Ranbaxy Laboratories Ltd last year, US inspectors found that a black fibre embedded in a tablet may have been a hair from an employee's arm, according...
View ArticleUS FDA for greater freedom to generic drug firms
US drug regulator Food and Drug Administration (FDA) plans to allow generic drug makers, including those from India, to independently update product labelling when they discover new safety data, a move...
View ArticleUh oh.. is Ranbaxy in more trouble?
The US Food and Drug Administration (FDA) has raised concerns about the manufacturing practices at a factory owned by Ranbaxy Laboratories, the drugmaker said on Monday, sending its shares down to...
View ArticleNow Ranbaxy’s fourth plant banned by FDA from making drugs for US
The US Food and Drug Administration said on Thursday it has banned more products from drugmaker Ranbaxy Laboratories from entering the United States due to manufacturing violations. The FDA said...
View ArticleFlies in sample storage room: What FDA report on Ranbaxy’s Toansa plant said
FDA banned the import of Ranbaxy products from its Toansa plant, halting the shipment of all the company's drugs to the US from India. The post Flies in sample storage room: What FDA report on...
View ArticleFDA bans Sun Pharma products made at Gujarat plant
The regulator has issued an import alert, which enables 'detention without physical examination of drugs from firms which have not met drug GMPs. The post FDA bans Sun Pharma products made at Gujarat...
View ArticleDr. Reddy’s recalling heartburn drug sold in US, says FDA
While product recalls are not uncommon, the FDA announcement comes amid a string of quality problems for Indian drug makers, including ban on Sun pharma imports today. The post Dr. Reddy’s recalling...
View ArticleDrugs sold in Indian markets safe, Ranbaxy tells SC
The Supreme Court today issued notice to Centre and Ranbaxy Laboratories on a PIL seeking cancellation of the company's licence and a CBI probe against it for allegedly supplying adulterated drugs in...
View ArticleUS doctors worried about drugs manufactured by Indian pharma
India supplies about 40 percent of generic and over-the-counter drugs used in the United States, making it the second-biggest supplier after Canada. The post US doctors worried about drugs manufactured...
View ArticleNearly 30,000 packs of allergy-relief drug recalled by Ranbaxy in US
All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches The post Nearly 30,000 packs of allergy-relief...
View ArticleWockhardt earnings hit by US FDA ban, Q1 profit plunges 94% to Rs 19.95 cr
Generic drugmaker Wockhardt on Tuesday said its quarterly net profit plunged 94 percent, as US Food and Drug Administration bans on its manufacturing plants continued to take a toll. The post Wockhardt...
View ArticleSun Pharma stock plummets: 5 reasons why it is getting hammered by investors
Majority of ex-Taro products of Sun Pharma for the US market come from the Halol facility The post Sun Pharma stock plummets: 5 reasons why it is getting hammered by investors appeared first on...
View ArticleWhy a Credit Suisse note has made Sun Pharma shoot up 6% in trade today
Sun Pharmaceutical Industries gained more than 6 percent today, heading towards its biggest single-day gain since April 9 after brokerage Credit Suisse said the pharma major has received a Form 483...
View ArticleMinor short term glitches: Indian pharma, Dalal St shouldn’t worry about US...
Indian pharma companies and the investors need not worry about be the US inspections and price actions The post Minor short term glitches: Indian pharma, Dalal St shouldn’t worry about US inspections...
View ArticleUS court rejects Ranbaxy request to block launch of rival Dr Reddy’s generic...
US court has denied a request by drugmaker Ranbaxy Laboratories to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte, a court filing...
View ArticleUS FDA cracks down on Dr Reddy’s Andhra plant
The US Food and Drug Administration (FDA) has found nine possible procedural deviations in a manufacturing plant of Dr Reddy's Laboratories during a recent inspection and has sought reply from the drug...
View ArticleNovartis sues Cipla for infringing respiratory drug patent
Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original...
View ArticleFresenius Kabi files suit against Claris Lifesciences over anesthesia drug
Claris Lifesciences today said US-based Fresenius Kabi has filed a suit against the company to block commercialisation of its abbreviated new drug application (ANDA) for Propofol, used to induce or...
View ArticleWockhardt recalls 12-15 drugs from US market; shares tumble up to 11%
The company clarified to CNBC-TV18 that it has taken measures to resolve the FDA's concerns The post Wockhardt recalls 12-15 drugs from US market; shares tumble up to 11% appeared first on Firstpost.
View ArticleIndia-made food products face USFDA heat, Haldiram’s top list of rejected items
According to the data tabled in the United States Food and Drug Administration (FDA) website, more food products from India have been rejected in the US in 2015 than that from any other country. The...
View Article
/fit-in/580x348/filters:format(webp)/english-betterindia/media/media_files/2026/09/17/balaghat-3-2026-09-17-18-46-40.png)
